Callan Capital’s Tarsus Pharmaceuticals TARS Stock Holding History

Callan Capital’s Portfolio TARS Stock Details TARS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$601K	Sell
2024 Q4	$664K	Sell
2024 Q3	$507K	Buy
2024 Q2	$402K	Buy
2024 Q1	$509K	Sell
2023 Q4	$343K	Buy
2023 Q3	$270K	Buy
2023 Q2	$267K	Buy
2023 Q1	$180K	Buy
2022 Q4	$170K	Buy